Pacira Biosciences, Inc. (PCRX)
36.34
+0.01
(+0.03%)
USD |
NASDAQ |
Oct 16, 16:00
36.34
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Cash from Operations (Quarterly) : 57.46M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.46M |
| March 31, 2026 | 25.68M |
| December 31, 2025 | 43.69M |
| September 30, 2025 | 60.83M |
| June 30, 2025 | 12.01M |
| March 31, 2025 | 35.46M |
| December 31, 2024 | 33.13M |
| September 30, 2024 | 53.92M |
| June 30, 2024 | 53.24M |
| March 31, 2024 | 49.10M |
| December 31, 2023 | 47.58M |
| September 30, 2023 | 44.44M |
| June 30, 2023 | 43.50M |
| March 31, 2023 | 19.13M |
| December 31, 2022 | 42.04M |
| September 30, 2022 | 42.65M |
| June 30, 2022 | 29.81M |
| March 31, 2022 | 30.78M |
| December 31, 2021 | 23.22M |
| September 30, 2021 | 60.29M |
| June 30, 2021 | 30.13M |
| March 31, 2021 | 12.08M |
| December 31, 2020 | 46.67M |
| September 30, 2020 | 39.78M |
| June 30, 2020 | -15.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.208M |
| December 31, 2019 | 25.90M |
| September 30, 2019 | 18.35M |
| June 30, 2019 | 22.76M |
| March 31, 2019 | 3.499M |
| December 31, 2018 | 21.22M |
| September 30, 2018 | 16.63M |
| June 30, 2018 | 13.71M |
| March 31, 2018 | -2.689M |
| December 31, 2017 | 16.93M |
| September 30, 2017 | -2.808M |
| June 30, 2017 | 3.656M |
| March 31, 2017 | 0.006M |
| December 31, 2016 | 17.35M |
| September 30, 2016 | 11.68M |
| June 30, 2016 | 7.541M |
| March 31, 2016 | -3.121M |
| December 31, 2015 | 17.04M |
| September 30, 2015 | 2.817M |
| June 30, 2015 | 8.651M |
| March 31, 2015 | -0.74M |
| December 31, 2014 | 13.14M |
| September 30, 2014 | 8.901M |
| June 30, 2014 | 10.58M |
| March 31, 2014 | -6.188M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Viatris, Inc. | 381.80M |
| Johnson & Johnson | -- |
| Liquidia Corp. | 80.24M |
| Organon & Co. | 107.00M |
| ANI Pharmaceuticals, Inc. | 56.67M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 11.76M |
| Cash from Financing (Quarterly) | -7.65M |
| Free Cash Flow | 179.52M |
| Free Cash Flow Per Share (Quarterly) | 1.393 |
| Free Cash Flow to Equity (Quarterly) | 55.19M |
| Free Cash Flow to Firm (Quarterly) | 62.72M |
| Free Cash Flow Yield | 11.72% |